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Melanoblasts are a population of neural crest-derived cells that generate the pigment-producing cells of
our body. Defective melanoblast development and function underlies many disorders including
Waardenburg syndrome and melanoma. Understanding the genetic regulation of melanoblast devel-
opment will help elucidate the etiology of these and other neurocristopathies. Here we demonstrate
that Magoh, a component of the exon junction complex, is required for normal melanoblast develop-
ment. Magoh haploinsufﬁcient mice are hypopigmented and exhibit robust genetic interactions with
the transcription factor, Sox10. These phenotypes are caused by a marked reduction in melanoblast
number beginning at mid-embryogenesis. Strikingly, while Magoh haploinsufﬁciency severely reduces
epidermal melanoblasts, it does not signiﬁcantly affect the number of dermal melanoblasts. These data
indicate Magoh impacts melanoblast development by disproportionately affecting expansion of
epidermal melanoblast populations. We probed the cellular basis for melanoblast reduction and
discovered that Magoh mutant melanoblasts do not undergo increased apoptosis, but instead are
arrested in mitosis. Mitotic arrest is evident in both Magoh haploinsufﬁcient embryos and in Magoh
siRNA treated melanoma cell lines. Together our ﬁndings indicate that Magoh-regulated proliferation of
melanoblasts in the dermis may be critical for production of epidermally-bound melanoblasts. Our
results point to a central role for Magoh in melanocyte development.
& 2013 Elsevier Inc. All rights reserved.Introduction
Melanocytes are specialized pigment-producing cells in verte-
brates derived from the multipotent embryonic neural crest
(Serbedzija et al., 1992, 1994). Melanocytes located in the
integument generate melanin pigment that is responsible in
mammals for coloration in skin and hair, and protection from
solar UV radiation (Miyamura et al., 2007). Defects in melanocyte
development and/or function are associated with multiple dis-
eases including albinism, Waardenburg syndrome, and piebald-
ism (Harris et al., 2010). Additionally, malignant transformation
of melanocytes causes melanoma, an extremely aggressive cancer
that poses a signiﬁcant health problem (Rigel, 2010). Thus, from
both a developmental and disease standpoint, there is a need to
understand the genes that regulate melanoblast function. In
particular, the genes that are important for melanocyte proliferationll rights reserved.
r Genetics and Microbiology,
USA. Fax þ1 919 684 2790.
rch Branch, National Human
A.
er),are thought to play a critical role in diseases of melanocytes, including
melanoma.
Melanoblasts develop from the neural crest coincident with
neural tube closure, which in mice occurs between embryonic
(E) day 8.5 and 9.5 (Cable et al., 1995; Erickson et al., 1992; Larue
et al., 2012; Silver et al., 2006). They migrate dorso-laterally
relative to the neural tube through the prospective dermis.
Between E9.5 and E13.5, they undergo dramatic expansion in
their population, rapidly proliferating and suppressing apoptosis.
Between E11.5 and E15.5, a subset of melanoblasts migrates from
the dermis into the epidermis and hair follicles, where they
eventually produce melanin (Luciani et al., 2011). The relation-
ship between dermal and epidermal melanoblasts was recently
hypothesized to be dependent upon precise cell divisions. Luciani
et al. proposed a model in which dermal melanoblasts undergo
asymmetric cell divisions to generate two populations: dermally
retained melanoblasts and dermal melanoblasts that migrate into
the epidermis (Luciani et al., 2011). This raises the interesting
possibility that expansion of melanoblasts in the dermis play a
critical role in the production of epidermal-bound melanoblasts.
In an effort to identify new genes critical for coordinated
melanocyte development, we recently carried out an N-ethyl-N-
nitrosourea (ENU) mutagenesis screen in mice. The screen was
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associated with haploinsufﬁciency for Sox10, a transcription
factor essential for the development of neural crest-derived
melanocytes and glia and for melanoma progression (Harris
et al., 2010; Matera et al., 2008; Prasad et al., 2011; Southard-
Smith et al., 1998). One novel hypopigmentation mutant identi-
ﬁed from this screen was Mos2 (modiﬁer of Sox10 spotting 2).
We previously used positional cloning to map the Mos2
mutation to Magoh (Silver et al., 2010). Magoh encodes a compo-
nent of the core exon junction complex (EJC). The EJC is an
assembly of proteins that binds to mRNA during splicing, subse-
quently promoting aspects of mRNA metabolism, including mRNA
splicing, localization, mRNA translation, and nonsense-mediated
decay (Ashton-Beaucage et al., 2010; Le Hir and Andersen, 2008;
Michelle et al., 2012; Nott et al., 2004; Palacios et al., 2004). We
previously demonstrated that Magoh haploinsufﬁciency causes
reduced body and brain size, due to defects in neural progenitor
division and altered neuron production (Silver et al., 2010).
However these analyses did not elucidate why Magoh haploin-
sufﬁciency causes hypopigmentation. In this study we have used
the MagohMos2/þ mouse model to deﬁne a critical role for Magoh
in melanoblast expansion.Materials and methods
Mouse genetics and husbandry
All mouse lines were maintained on a C57BL/6J background.
The MagohMos2/þ and Sox10LacZ/þ lines were genotyped as pre-
viously described (Matera et al., 2008; Silver et al., 2010). Dct-
LacZ mice were used as previously described (Silver et al., 2008).
All of the mice described were bred and housed in an NHGRI
animal facility according to NIH guidelines. Animal care was done
in accordance with NHGRI institutional standards and was
approved by the Institutional Animal Care and Use Committee,
NHGRI, and NIH Institutional Review Board.
Whole mount staining
b-galactosidase activity staining was performed as previously
described (Silver et al., 2008). In situ hybridization was performed
using Dct or Pmel17 probes, as previously described (Silver et al.,
2008). Images of whole mount embryos were taken using a digital
camera mounted on a Leica M125 Dissecting microscope.
Tissue sections staining
b-galactosidase-stained embryos were embedded in parafﬁn
and 5 mM sections were made. Parafﬁn was removed using a
series of Xylene washes and sections were counterstained with
hematoxylin and eosin staining. For immunoﬂuorescence, frozen
sections were prepared from embryos ﬁxed overnight in 4%
paraformaldehyde, washed in PBS, and placed in 10% and 20%
sucrose solutions overnight. 20 mm sections were prepared
through the trunk in coronal orientation. The following antibodies
were used at 1:200: mouse anti-b-galactosidase (Promega, Madi-
son, WI), rabbit anti-cleaved Caspase-3 (Cell Signaling, Danvers,
MA), rabbit anti-phospho-Histone H3 (Upstate Biotechnology,
Temecula, CA), and anti-mouse and anti-rabbit FITC-conjugated
and rhodamine-conjugated secondary antibodies (Invitrogen, CA).
Staining was performed using the MOM kit and Vectashield
mount with DAPI (Vector Labs). For images of mouse skin, skins
were peeled from embryos, and ﬂattened with a coverslip. Images
of tissue sections were taken using a Zeiss Axioskop2 microscope
with IPLab imaging software.Quantitation of whole mount embryos and tissue sections
Quantitation of melanoblasts in whole mount in situ hybridi-
zations was performed as previously described (Loftus et al.,
2009). Brieﬂy, melanoblast density was measured in several
pre-deﬁned regions, as shown in Fig. 3E, and as follows: Region
A contains the melanoblasts found in the crease between the
telencephalon and nasal process, extending towards the eye;
Region C contains the area between the caudal boundary line
from the eye to the mid- hindbrain in region B and a parallel line
immediately anterior to the otic vesicle; Region E contains the
melanoblast population lateral to the forelimb area; and Region F
contains the melanoblasts present in the trunk as deﬁned by the
post-axial (caudal) side of the forelimb bud, throughout the trunk,
up to the preaxial (anterior) side of the hindlimb bud. Quantita-
tion was then performed using the following scale: 0¼no mela-
noblasts; 1o12 melanoblasts within the region; 2¼moderate
number of melanoblasts, sparsely distributed; 3¼even, numerous
melanoblasts; 4¼dense overlapping melanoblasts.
Quantitation of total, epidermal, and dermal melanoblast
number in 20 mm sections was calculated by measuring LacZ-
positive melanoblast number per section. The epidermis was
deﬁned morphologically by a layer of 2–3 nuclei deep above the
basal membrane. Melanoblasts below the basal membrane were
classiﬁed as dermal. At least 10 sections/embryo were measured
to give an average value for each embryo. At least 3 embryos were
quantiﬁed per genotype and averaged to give the values graphed
in Fig. 5 and Supplementary Fig. 2. Quantitation of the apoptotic
index and mitotic index per section were calculated using cleaved
caspase-3- (CC3) or phospho-histone H3- (PH3) positive melano-
blasts, as previously described, for at least 3 embryos/genotype
and for at least 10 sections/embryo (Silver et al., 2008). P values
were calculated using a student’s t-test.Cell culture analysis
ISE06 human melanoma cell-line were transfected withMagoh
or control siRNAs. Cells were harvested for lysates or ﬁxed in
ethanol overnight for cell-cycle analysis 48 h after transfection.
DNA content of ﬁxed cells was measured by ﬂow cytometry with
propidium iodide staining. Western blots were performed to
determine the efﬁciency of Magoh knockdown. For analysis of
MEF growth, MEFs were generated from E14.5 littermate embryos
as previously described (Silver et al., 2010). MEFs were cultured
for two passages and the third passage of MEFs were used for
analysis. Equal numbers of MEFs (100,000 cells) were plated at
day 0 and then counted after 48 h in culture manually with a
hemocytometer. For the control two independent MEF lines were
averaged for þ /þ;Tg-BAC and for the mutant four independent
MEF lines were averaged.Quantitative RT-PCR
Gene expression was measured in primary human melano-
cytes and human and mouse cell lines using the Taqman real-time
PCR gene expression assays: Magoh (Mm00487546_m1) and
Magoh (Hs00830672_s1) from Applied Biosystems. The expres-
sion in each sample was normalized to Gapdh and conditions
were used as previously described (Silver et al., 2010). For
analysis of MAGOH expression in human melanoma cells the
comparative Ct approach was used. For analysis of Magoh expres-
sion in primary melanocytes and melan-A cells, expression was
generated relative to a standard curve.
Table 1
Distribution of mice with hypopigmentation patterns.
Hypopigmentation phenotype Number mice % Of mice
Small ventral spot 3 16
Large ventral spot AND 13 68
Small dorsal spot
Large ventral spot AND 3 16
Dorsal belt
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Haploinsufﬁciency for Magoh results in dorsal and ventral
hypopigmentation
To ﬁrst assess the role of Magoh in establishment of pigmenta-
tion, we performed a detailed evaluation of the coat color
phenotype in MagohMos2/þ adult mice. The hypopigmentation
phenotype was 100% penetrant, as allMagohMos2/þ mice exhibited
ventral hypopigmentation (n¼42 mice) (Fig. 1). We examined 19
MagohMos2/þ mice in more detail (Table 1). Of these, 16% (n¼3)
exhibited hypopigmentation only on their ventrum, evident as
small white spots such as exempliﬁed in Fig. 1B. 68% (n¼13) of
MagohMos2/þ mice exhibited more extensive hypopigmentation,
apparent on both ventral and dorsal surfaces (Fig. 1A). In these
mice, the ventral spot was quite large, extending between the
forelimb and hindlimb regions while the dorsal spot was evident
in a belt-like pattern at the midline of the torso. In the remaining
MagohMos2/þ mice, the area of dorsal hypopigmentation was
noticeably larger and extended more laterally (16%, n¼3). Strik-
ingly, in 84% of MagohMos2/þ mice examined (n¼16), the ventrum
showed white spotting surrounding a narrow, band-like pattern
of pigmentation present in the midline (dubbed ‘‘oak tree’’)
(Fig. 1A,B, lower panels). In these mice the oak tree was always
more prominent in the posterior of the ventrum than the anterior.
The hypopigmentation and oak tree pattern were observed in the
MagohMos2 allele, as well as in two independent alleles generated
from gene traps, MagohGT27/þ and MagohGT51/þ (Fig. 1B) (Silver
et al., 2010). While the oak tree pattern has not previously been
observed in other pigmentation mutants, the ventral spotting and
belting are similar to those seen in other mouse pigment mutants,
including Adamts20/Belted, Pax3/Splotch, and Ednrb/Piebald
(http://www.informatics.jax.org) (Baxter et al., 2010; Silver
et al., 2008). Together this analysis indicates that Magoh inﬂu-
ences pigmentation on both dorsal and ventral regions of the
adult mouse.
Next we assessed pigmentation in mice haploinsufﬁcient for
both Sox10 and Magoh (MagohMos2/þ;Sox10LacZ/þ). The MagohMos2/þ
phenotype was originally identiﬁed from a genetic interaction
screen with Sox10, in which MagohMos2/þ;Sox10LacZ/þ mice exhib-
ited increased hypopigmentation as compared to Sox10LacZ/þ mice
(Matera et al., 2008). The initial screen was performed on a mixed
Balb/cJ and C57Bl/6J genetic background. Therefore we tested if
Magoh and Sox10would genetically interact on an inbred C57Bl/6JFig. 1. Magoh haploinsufﬁcient mice exhibit hypopigmentation. (A–C) Lateral and ven
(C) MagohMos2/þ; Sox10LacZ/þ .background. We discovered that MagohMos2/þ;Sox10LacZ/þ mice on a
C57Bl/6J background exhibited genetic interactions similar to those
seen on a mixed background (Fig. 1C) (Matera et al., 2008). This
indicates that the inbred C57Bl/6J background introduced no new
modiﬁer effects. We next analyzed the pigmentation pattern of
MagohMos2/þ;Sox10LacZ/þ mice on the C57Bl/6J background in more
detail. MagohMos2/þ;Sox10LacZ/þ mice showed a much larger region of
ventral and dorsal hypopigmentation than that seen in MagohMos2/þ
alone (compare Fig. 1C to A, B). Strikingly, while the extent of
hypopigmentation is synergistically increased in MagohMos2/þ;
Sox10LacZ/þ mice, these mice show no evidence of the pigmented
oak tree pattern present in MagohMos2/þ mice (100%, n¼4). This
indicates that the Sox10 mutation is epistatic to Magoh for the oak-
tree phenotype.
Sox10-positive melanoblast development is impaired in MagohMos2/þ
embryos
The belly spot phenotype observed in MagohMos2/þ and
MagohMos2/þ;Sox10LacZ/þ mutant mice indicated thatMagohmight
affect pigmentation by regulating melanoblast development. To
test this potential function for Magoh, we compared melanoblast
development in Sox10LacZ/þ andMagohMos2/þ;Sox10LacZ/þ embryos
at developmental time points spanning from the initial to late
stages of melanoblast development (E11.5–E16.5) (Fig. 2). The
Sox10LacZ/þ allele drives LacZ expression in melanoblasts as well as
other neural crest derivatives during embryonic development
(Britsch et al., 2001), thus allowing us to use b-galactosidase activity
to mark the Sox10-expressing cells in whole embryos. At E11.5,
there was no notable difference in Sox10-positive melanoblasts in a
MagohMos2/þ background (Fig. 2A, B). However beginning at E12.5
we observed a striking reduction in Sox10-positive cells in the
MagohMos2/þ;Sox10LacZ/þ embryos (Fig. 2C–F). Melanoblasts were
reduced in the trunk laterally between both limbs, but not in the tailtral views of mice of the following genotypes: (A) MagohMos2/þ , (B) MagohGT27/þ ,
Fig. 2. Analyses of melanoblast development in MagohMos2/þ;Sox10LacZ/þ embryos show that Magoh genetically interacts with Sox10. (A–F) Images of b-galactosidase-
stained whole mount Sox10LacZ/þ (A,C,E) and MagohMos2/þ;Sox10LacZ/þ embryos (B,D,F) at E11.5 (A,B) and E12.5 (C–F). (E,F) High magniﬁcation view of region outlined in
boxes in (C,D). (G–N) Images of the underside of skin from b-galactosidase-stained Sox10LacZ/þ (G,I,K,M) and MagohMos2/þ;Sox10LacZ/þ embryos (H,J,L,N) at E14.5 (G,H),
E15.5 (I,J), and E16.5 (K–N). (M,N) High magniﬁcation view of region outlined in boxes in (K,L). (O,P) High magniﬁcation images of b-galactosidase-stained whole mount
E16.5 Sox10LacZ/þ and MagohMos2/þ; Sox10LacZ/þ embryos. (Q,R) Parafﬁn sections of b-galactosidase-stained and H & E-stained integument from E16.5 Sox10LacZ/þ and
MagohMos2/þ;Sox10LacZ/þ embryos. Note Sox10LacZ/þ shows expression in both melanoblasts (of the dermis and epidermis) as well as in the peripheral nervous system.
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E16.5 embryos (Supplementary Fig. 1). Analysis of the underside of
the embryonic skin provided additional evidence that the Sox10-
positive melanocytes in the integument were signiﬁcantly reduced
between E14.5 and E16.5 (Fig. 2G–N). These data collectively
indicate that beginning at E12.5, melanoblasts are reduced in
MagohMos2/þ;Sox10LacZ/þ embryos.
At E16.5, melanoblasts normally have begun to migrate into
hair follicles, as evidenced by large blue clusters marking the hair
follicles of Sox10LacZ/þ embryos (Fig. 2O) (Silver et al., 2006).
However in the MagohMos2/þ;Sox10LacZ/þ embryos, there was a
dramatic reduction in these follicle-associated melanoblast clus-
ters (Fig. 2P). Histological analysis of E15.5 and E16.5 skin
sections revealed that Sox10-positive melanoblasts were absent
from developing hair follicles and signiﬁcantly reduced in the
epidermis of MagohMos2/þ;Sox10LacZ/þ embryos (Fig. 2Q,R, data
not shown). We also observed some reduction in Sox10-positive
neural crest derivatives in the dermis (evident by morphology).
The reduction in hair follicle melanoblasts inMagohMos2/þ;Sox10LacZ/þ
embryos was not due to defective hair follicle formation as
histological analysis indicated that hair follicles formed similarlyand properly in the age matched MagohMos2/þ;Sox10LacZ/þ and
Sox10LacZ/þ embryos (Fig. 2Q,R). Together these data indicate that
Magoh is required for development of a proper number of Sox10-
positive trunk melanoblasts, particularly in the epidermis.
Magoh is required for melanoblast development independent
from the Sox10 mutation
Given that Magoh haploinsufﬁcient mice are hypopigmented
in the absence of a Sox10 mutation, we hypothesized that the
Magoh mutation alone would also impair melanoblast develop-
ment. To examine melanoblast development in MagohMos2/þ
embryos without the Sox10LacZ/þ mutation, we performed
in situ hybridization against the melanoblast gene, Pmel17, on
whole mount E11.5 and E12.5 embryos (Baxter and Pavan, 2003).
We observed no qualitative differences in melanoblasts between
C57BL/6J (control) and MagohMos2/þ embryos at either age
(Fig. 3A–D). In situ hybridization at E12.5 against mRNA expres-
sion of another melanoblast marker, Dct, also showed similar
results (data not shown). We quantiﬁed the distribution and
number of Pmel17-positive melanoblasts in four regions of these
Fig. 3. In situ hybridization analyses show melanoblasts are distributed normally in E11.5 and E12.5 MagohMos2/þ embryos. (A–D) Images of whole mount Pmel17 in situ
hybridizations of control (A,C) and MagohMos2/þ (B,D) embryos at E11.5 (A,B), and E12.5 (C,D). (E) Quantitation of density of embryonic melanoblasts at E11.5 and E12.5
from speciﬁc anatomical regions, as indicated in schematic on right. A score was assigned as described in the materials and methods. Error bars¼standard deviation. Note
that there was no signiﬁcant difference observed between control and mutants.
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our lab (Fig. 3E) (Loftus et al., 2009). This analysis also revealed no
signiﬁcant difference between control and MagohMos2/þ embryos
at these early stages of melanoblast development (Fig. 3E).
We next evaluated melanoblast development in MagohMos2/þ
embryos using a transgenic marker of melanoblasts, Dct-LacZ.
Similar to the in situ hybridization results, E11.5 and E12.5 whole
mount MagohMos2/þ; Dct-LacZ embryos showed no overt reduc-
tion in melanoblast distribution compared to Dct-LacZ (control)
embryos (Fig. 4A–D and data not shown). Taken together, these
data indicate that at E11.5 and E12.5, melanoblast number is
relatively normal in MagohMos2/þ embryos. This result contrasts
with the timing of defects in MagohMos2/þ;Sox10LacZ/þ embryos,
which are evident at E12.5.
We next evaluated melanoblast development in older E13.5
and E14.5 MagohMos2/þ; Dct-LacZ and control embryos to deter-
mine if there is a melanoblast defect at later stages. In control
E13.5 embryos, melanoblasts are normally distributed laterally
and throughout the head region (Fig. 4E,G) (Silver et al., 2006).
However in E13.5 MagohMos2/þ; Dct-LacZ embryos, there was a
noticeable reduction in Dct-LacZ positive melanoblasts in the
lateral lumbar regions, and a slight reduction in the head
(Fig. 4F,H). Similar differences between MagohMos2/þ; Dct-LacZ
and control embryos were also evident at E14.5 (Fig. 4I–L). In
E14.5 control embryos, melanoblasts are evenly distributed acrossthe length of the embryo, covering all surfaces except the
ventrum adjacent to the umbilical cord (Fig. 4I,K, data not shown).
However in E14.5 MagohMos2/þ; Dct-LacZ embryos, there was a
marked reduction in melanoblasts in the trunk, with a large
ventral area devoid of Dct-LacZ-positive cells (Fig. 4J). There was
also a slight but noticeable reduction in the head (Fig. 4L). Of note,
in the MagohMos2/þ; Dct-LacZ embryos there was no evidence of
melanoblasts ﬁlling in the ventral region, where the ‘‘oak tree’’
was observed in adult mice (data not shown). Together these
results indicate that Magoh haploinsufﬁciency causes a reduction
in both trunk and head melanoblasts by E13.5. Because the
MagohMos2/þ;Sox10LacZ/þ phenotype was evident prior to this
stage, our results indicate that one way the Sox10 mutation
exacerbates the melanoblast defect in MagohMos2þ / embryos is
by affecting an earlier stage of melanoblast development.
Magoh haploinsufﬁciency results in striking changes in melanoblast
number and location
To further elucidate how Magoh inﬂuences melanoblast devel-
opment, we quantiﬁed melanoblast number and distribution in
embryonic sections from MagohMos2/þ; Dct-LacZ and control
embryos. Consistent with our analyses of whole mount embryos,
the average number of melanoblasts/section at E12.5 was not
signiﬁcantly different betweenMagohMos2/þ; Dct-LacZ and control
Fig. 4. Magoh distribution is defective in whole mount MagohMos2/þ embryos at E13.5 and E14.5. (A–L) Images of b-galactosidase stained whole mount Magohþ /þ;
Dct-LacZ (Dct-LacZ) (A,E,I,C,G,K) and MagohMos2/þ; Dct-LacZ embryos (B,F,J,D,H,L) at E12.5 (A–D), E13.5 (E–H), and E14.5 (I–L).
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(Fig. 5A). In contrast, at E13.5 there was a 30% reduction in
MagohMos2/þ; Dct-LacZ melanoblasts compared to control
(average¼22/section versus 32/section respectively, Po0.00001)
(Fig. 5A). At E14.5 this difference was even more pronounced, with
an 80% reduction in MagohMos2/þ; Dct-LacZ melanoblasts compared
to control (average¼27/section versus 70/section respectively,
Po0.00001). These quantitative analyses reveal two important ﬁnd-
ings. First, differences in melanoblast numbers between control and
Magoh mutants increased strikingly from E13.5 to E14.5 as develop-
ment proceeded. Second, the average melanoblast number in
MagohMos2/þ embryos remained relatively constant from E13.5 to
E14.5 while control melanoblasts increased in density over this time
period.
To evaluate whether melanoblast distribution within the devel-
oping integument was altered in MagohMos2/þ embryos, we quanti-
ﬁed melanoblasts in dermal and epidermal layers of E13.5 and E14.5
sections from MagohMos2/þ; Dct-LacZ and control embryos. There
were no signiﬁcant difference in the number of dermal melanoblasts
of control and MagohMos2/þ;Dct-LacZ E13.5 embryos (9 versus 9.4,
respectively, P¼0.79) or E14.5 embryos (9.2 versus 12.3, respectively,
P¼0.24) (Fig. 5B). In contrast, there were signiﬁcantly more epider-
mal melanoblasts in control embryos compared to MagohMos2/þ;
Dct-LacZ embryos at both E13.5 and E14.5 (Fig. 5C). At E13.5 this
difference was 23.9 melanoblasts/section versus 13.4 for control and
MagohMos2/þ;Dct-LacZ embryos, respectively (Po0.00001). This dif-
ference was even more pronounced at E14.5, when control embryos
contained a ﬁve-fold higher epidermal melanoblast number than
seen in MagohMos2/þ;Dct-LacZ embryos (compare 64.5 versus 14.8
respectively, Po0.00001). Together these data indicate that Magoh
exerts a major effect upon melanoblast development and is required
to achieve normal epidermal melanoblast number.
Magoh haploinsufﬁciency does not affect melanoblast survival
but does cause mitotic arrest
The melanoblast reduction is ﬁrst evident in E13.5 MagohMos2/þ
embryos, which is a critical time point in melanoblast developmentfor expansion of the melanoblast population. At this stage melano-
blasts expand in number by both rapid proliferation and by exerting
pro-survival mechanisms (Mackenzie et al., 1997; Silver et al., 2006;
Silver et al., 2008). We predicted Magoh haploinsufﬁciency could
deplete melanoblasts by either of these mechanisms. To test this, we
ﬁrst we examined whether there was increased melanoblast apop-
tosis in MagohMos2/þ;Dct-LacZ embryos, by calculating apoptotic
indices in control and MagohMos2/þ;Dct-LacZ embryos (see Fig. 5D,
F–H). We measured melanoblast apoptosis in E12.5–E14.5 embryos
because these ages span the observed melanoblast phenotype. At
E12.5 there was no signiﬁcant increase in the apoptotic index in
control versus MagohMos2/þ;Dct-LacZ embryos (0.72% versus 0.83%,
respectively, P¼0.3437) (Fig. 5D). This result is consistent with
normal melanoblast number observed in MagohMos2/þ;Dct-LacZ at
this age. At E13.5, the apoptotic index was also not signiﬁcantly
different between control and MagohMos2/þ;Dct-LacZ embryos (0.36
versus 1.1, respectively, P¼0.182). Similar results were seen at E14.5,
when the apoptotic index was 0.29 and 0.31 in control and
MagohMos2/þ;Dct-LacZ embryos, respectively (P¼0.9039). Together
these quantitative analyses indicate that the gross reduction in
melanoblast number inMagohMos2/þ embryos is not due to increased
melanoblast apoptosis. This is in contrast to other mutants, such as
belted, which exhibit loss of melanoblasts due to apoptosis (Silver
et al., 2008).
We hypothesized that the reduced melanoblast number in
MagohMos2/þ embryos could be due to defects in melanoblast
proliferation. Therefore we determined whether melanoblasts in
E12.5–E14.5 MagohMos2/þ;Dct-LacZ embryos underwent altered cell
division by calculating average mitotic indices (Fig. 5E, H–J,
Supplementary Fig. 2). In E12.5 control and MagohMos2/þ;Dct-LacZ
embryos, the average mitotic index was not signiﬁcantly different
(2.1 versus 2.27 respectively, P¼0.8098; Supplementary Fig. 2). This
result is consistent with the observation that melanoblast number in
E12.5 MagohMos2/þ embryos is normal (Fig. 5A). However, E13.5
MagohMos2/þ;Dct-LacZ embryos showed a striking ﬁve-fold increase
in mitotic index relative to control embryos (4.26 versus
0.93, respectively, P¼0.007; Fig. 5H). This trend continued in
E14.5 embryos, with a two-fold increase in the mitotic index of
Fig. 5. Reduced melanoblast number and increased melanoblast proliferation in MagohMos2/þ embryos. (A–C) Graphs showing average melanoblast number/section in
Magohþ /þ; Dct-LacZ (control) and MagohMos2/þ; Dct-LacZ at E12.5, E13.5, and E14.5, including: total number of melanoblasts (A), total number of dermal melanoblasts (B),
and total number of epidermal melanoblasts (C). (D) Graph representing average percentage of total melanoblasts that are CC3-positive at E12.5, E13.5, and E14.5.
(E) Graph representing average percentage of total melanoblasts that are PH3-positive at E13.5. For A–E, each graphed point represents the average value of 3 independent
embryos, with each embryo value averaged from at least 10 sections. (F–K) Representative immunoﬂuorescence images of coronal sections stained for LacZ (melanoblasts,
red) and either CC3 (apoptotic cells, green) (F–H) or PH3 (mitotic cells, green) (I–K). DAPI (blue) shows nuclei, and arrows indicate examples of co-labeled cells in the
dermis (F–H) and epidermis (H–J). Error bars¼standard deviations. NS¼not signiﬁcant. ***, Po0.00001. In (I–K) a dotted line denotes the edge of the skin, and D¼dermal
melanoblast and E¼epidermal melanoblast. (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
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was not statistically signiﬁcant (2.05 versus 1.26, respectively,
P¼0.17; Supplementary Fig. 2). Together these results indicate that
Magoh haploinsufﬁciency causes mitotic arrest and impairs melano-
blast proliferation. In light of our ﬁnding that melanoblasts are
signiﬁcantly reduced in number at E13.5, we conclude that melano-
blasts are depleted in large part due to failure to expand in number.
Reduced Magoh expression in melanocyte-derived cells causes
G2/M mitotic arrest
To further examine how Magoh inﬂuences melanoblast expan-
sion, we used a cell culture model. We ﬁrst measured Magoh
mRNA expression in different sources of melanocytes, including a
mouse melanocyte cell line (melan-a), human primary melano-
cytes, and a panel of human melanocyte-derived cell lines
(Supplementary Fig. 3). This analysis revealed that Magoh is
expressed in both primary and immortalized melanocyte-
derived cell lines. We selected the melanoma cell line, ISE06 for
functional siRNA analysis because this cell line is amelanocytic,
making it possible to do propidium iodide staining and cell cycle
analysis. Moreover,Magoh is expressed at a moderate level in this
cell line, making it feasible to knock-down its endogenous
expression. Using siRNA knockdown of Magoh in ISE06 cells,we achieved a dramatic reduction in Magoh protein levels as
compared to control cells (Fig. 6A). We then carried out FACs
analyses of these cells to measure the DNA content and cell cycle
stage (Fig. 6B). This analysis showed that the siRNA-mediated
knockdown of Magoh expression in the ISE06 cell line signiﬁ-
cantly increased the percentage of cells in G2/M (Magoh
siRNA¼36%, scrambled siRNA¼11%, untreated¼12%). To deter-
mine if Magoh haploinsufﬁciency impacted net cell number we
quantiﬁed growth of MagohMos2/þ mouse embryonic ﬁbroblasts
(MEFs, passage 3) in culture (Supplementary Fig. 4). We found
that after 48 hours in culture, there were signiﬁcantly fewer
MagohMos2/þ MEFs compared to control (Po0.0045). This trend
was also evident in passage 2 MEFs (data not shown). Taken
together, these results indicate that reduced Magoh expression
causes mitotic arrest at G2/M and impacts cell number. These
in vitro ﬁndings are consistent with the increased number of
mitotic melanoblasts (PH3-positive) and with the net reduction in
melanoblasts observed in Magoh haploinsufﬁcient embryos.Discussion
In this paper, we demonstrate that Magoh is an essential
regulator of melanoblast development. Magoh haploinsufﬁcient
Fig. 6. Magoh depletion from a melanocyte-derived cell line causes G2/M arrest. (A) Immunoblots depicting Magoh and Tubulin protein expression in untreated, scrambled
siRNA-treated, and Magoh siRNA-treated ISE06 cells. (B) Representative FACs proﬁles of untreated, scrambled siRNA-treated, and Magoh siRNA-treated ISE06 cells.
Pie charts below each proﬁle depict the proportion of cells in each phase of the cell cycle.
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melanoblast number during development. We ﬁnd that this
reduction is due to defects in melanoblast expansion that pre-
dominantly affect epidermal melanoblast populations. Moreover,
the ﬁnding that Magoh depletion from a melanoma cell line
causes cell cycle arrest indicates that inﬂuencing Magoh expres-
sion in melanomas could provide possible therapeutic options for
these diseases. Together our study establishes Magoh as a new
central regulator of melanocyte development, and thus has
implications for our understanding of the genetic basis of mela-
nocyte development disorders.
Magoh regulates melanoblast number
Normal melanoblast development requires the successful
execution of multiple processes, including initial speciﬁcation,
migration, active cell survival, and extensive proliferation (Cable
et al., 1995; Harris et al., 2010; Serbedzija et al., 1992; Silver et al.,
2006). Through our analyses of melanoblast development, we
pinpointed which of these processes are disrupted inMagohMos2/þ
embryos. Melanoblast speciﬁcation and dorso-lateral migration
from the neural tube is intact in Magoh mutants, as evidenced by
the presence of Dct-positive and Pmel17-positive melanoblasts in
the proper number and location in younger embryos. Magoh
haploinsufﬁciency also does not disrupt melanoblast survival, as
there was no increase in apoptotic indices of mutant melano-
blasts. However, we found thatMagoh is essential for proliferation
of melanoblasts at a critical time in melanoblast expansion
(Mackenzie et al., 1997). Hence, mitotic arrest of melanoblasts
in Magoh mutants leads to an overall reduction in melanoblasts.
The reduced pattern of melanoblasts during embryogenesis is
more dramatic then the adult hypopigmentation seen in Magoh
haploinsufﬁcient mice. We observed fewer melanoblasts through-
out the head and trunk of MagohMos2/þ embryos, however the
mutant adults only exhibited trunk hypopigmentation. This is
similar to other mutants such as Adamts20bt/bt, in which there are
reduced melanoblasts in the head of mutant embryos, but
no cranial hypopigmentation in the adult (Silver et al., 2008).
This difference is likely due to the fact that there are moremelanocytes in the head and thus a loss of melanocytes during
embryogenesis does not affect overall pigmentation pattern in the
head (Silver et al., 2008; Wilkie et al., 2002). It is also possible that
the belly spot observed in MagohMos2/þ adults may be caused by
melanocytes that fail to produce or transfer melanin. Another
difference between embryonic and adultMagohMos2/þ phenotypes
is the ‘‘oak-tree’’ pattern. In the adult Magoh haploinsufﬁcient
mice some pigmentation is evident within the ventral midline of
the trunk, yet inMagoh haploinsufﬁcient embryos we observed no
evidence of melanoblasts populating the ventral trunk midline.
We speculate that there may be a population of Magoh-indepen-
dent melanoblasts that proliferates late in development within
the ventral midline. Future studies using conditional temporal
deletion of Magoh will be helpful to test this possibility.
While haploinsufﬁciency forMagoh reduces melanoblast num-
ber as early as E13.5, combined haploinsufﬁciency for both Sox10
and Magoh reduces melanoblast number one day earlier in
development. These phenotypes persist into adulthood, resulting
in more extensive hypopigmentation in MagohMos2/þ;Sox10LacZ/þ
embryos relative to that seen in either Sox10 or Magoh single
mutants. This genetic interaction may be due to Magoh and Sox10
acting in the same genetic pathway. Another explanation is that
dosage of both genes is critical for melanoblast development but
that each gene acts at a different time. Many genes known to
regulate melanoblast development show dosage-dependent phe-
notypes as well as genetic interactions with other melanoblast
genes (Silver et al., 2008). Indeed our results are compatible with
both possibilities. For example, while Sox10 haploinsufﬁciency is
known to affect early melanoblast speciﬁcation and survival, our
study reveals that Magoh affects later melanoblast proliferation
(Potterf et al., 2001; Southard-Smith et al., 1998). Further analyses
will be helpful to elucidate the molecular relationship between
Sox10 and Magoh and whether Magoh also interacts with other
melanoblast mutants.
Magoh regulates melanoblast expansion
We propose that Magoh enables melanoblasts to proceed
through the cell cycle, and speciﬁcally through G2/M phases.
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Magoh deﬁcient cells are arrested at G2/M and reduced in
number, and our in vivo analyses of Magoh mutants, which have
increased number of melanoblasts labeled with PH3, a marker for
G2/M. Thus our data indicate that at E13.5 Magoh deﬁcient
melanoblasts are arrested in G2/M, and ultimately fail to expand,
leading to a net reduction in melanoblasts at E13.5 and E14.5. At
E14.5 the trend of more PH3 positive melanoblasts in Magoh
haploinsufﬁcient mutants continued, although it was not statis-
tically signiﬁcant. We speculate that at E13.5, melanoblasts may
be especially sensitive to perturbations of the cell cycle, as other
pigmentation mutants affect cell number at this age (Silver et al.,
2008; Yoshida et al., 1996).
Our ﬁndings are consistent with a generalized role for Magoh
in mitosis. siRNA knockdown of Magoh in HeLa cells causes G2/M
arrest (Kittler et al., 2007; Silver et al., 2010). Moreover, similar to
our in vitro ﬁndings with MEFs and melanocyte-derived cells,
Magoh siRNA treated tsFT210 and FM3A cells show reduced
proliferation in culture (Inaki et al., 2011). How might Magoh
impact melanoblast division? We previously found that Magoh
was required for chromosome segregation of MagohMos2/þ MEFs
and for bipolar spindle formation of HeLa cells (Silver et al., 2010).
Thus we predict that Magoh impacts melanoblast proliferation
using similar cell biological mechanisms. At a molecular level, we
postulate that Magoh may regulate expression of cyclin-
dependent kinases (Cdks), as demonstrated by Inaki et al. (Inaki
et al., 2011).
Our ﬁndings in melanocytes are consistent with a generalized
role for Magoh in mitosis during development. In the developing
cerebral cortex, we previously showed that Magoh regulates
mitosis and cleavage planes of neural stem cells (Silver et al.,
2010). Magoh haploinsufﬁcient mice exhibit alterations in neuro-
genesis, with precocious production of neurons and loss of neural
progenitors (Silver et al., 2010). Although ectopically produced
neurons in the brain undergo cell death, such cell death is not
apparent in Magoh-deﬁcient melanoblasts. These differences
could reﬂect cell-type speciﬁc responses to mitotic arrest. For
example, melanoblasts may be more resilient in correcting DNA
damage, in line with their ability to survive under DNA-damaging
UV irradiation (Harris et al., 2010; Miyamura et al., 2007).
Alternatively, it is also possible that apoptotic melanoblasts lost
expression of melanoblast markers, making them undetectable in
this study.
Magoh impacts epidermal melanoblasts
One surprising ﬁnding to come out of our study is that Magoh
haploinsufﬁciency disproportionately affects epidermal melano-
blasts. This is likely not due to a simple reduction in proliferation,
because other mouse spotting mutants that affect melanoblast
proliferation do not always show disproportionate effects upon
epidermal and dermal populations. For example, Delmas and
colleagues examined melanocyte development using mice with
gain- and loss-of-function mutations in b-catenin (Luciani et al.,
2011). They found that both types of alterations resulted in
reduced numbers by affecting proliferation, however both the
dermal and epidermal melanoblasts were reduced. They used
results from this study to develop a mathematical model in which
half of the progeny of dermal melanoblasts undergoing cell
division give rise to cells that remain in the dermis, while the
other half migrate from the dermis to the epidermis (Aylaj et al.,
2011). This raises the interesting possibility that expansion of
melanoblasts in the dermis plays a critical role in the production
of epidermal-bound melanoblasts. Given the role of Magoh in
speciﬁcation of neurons in the brain, it is tempting to speculate
that Magoh is similarly involved in regulating the fate of cellsgenerated from melanoblast divisions in the dermis. Thus the
daughter cells derived from dermal melanoblasts in Magoh
mutants could be compromised in their function and incapable
of entering the epidermis. This cell fate mechanism could explain
the extensive defect in epidermal melanoblasts seen in Magoh
mutants.
An alternative explanation for the disproportionate reduction
in epidermal melanoblasts is that Magoh inﬂuences Schwann cell
precursors, which also generate melanocytes during development
(Adameyko et al., 2009). Recent studies by Adamyeko and
colleagues described a population of developing melanoblasts
arising from multipotent Schwann cell precursors located near
cutaneous nerves that can ﬁrst be identiﬁed between E12 and
E13. This time period also marks the onset of the melanocyte
phenotype in Magoh mutants. The Schwann cell precursors have
been proposed to generate melanocytes that contribute mainly to
the epidermal melanocytes while the dorsolaterally migrating
cells contribute mainly to dermal populations. Magoh could
function in at least two ways in Schwann cell precursors. First,
Magoh could inﬂuence cell division of the Schwann cell precursors
leading to subsequent reductions in the population of epidermal
melanoblasts. Second, similar to Magoh’s role in cell fate speciﬁ-
cation in the brain, it could affect melanocyte speciﬁcation by
Schwann cell precursors, inﬂuencing whether their daughter cells
generate progeny destined for Schwann cell or a melanocyte fates
(Adameyko et al., 2009; Silver et al., 2010).
It is also striking to note thatMagoh haploinsufﬁciency causes cell-
speciﬁc phenotypes affecting primarily the brain and melanocytes.
Because Magoh encodes a component of the exon junction complex
(EJC) that mediates various aspects of mRNA metabolism, a reason-
able a priori prediction would be that Magoh haploinsufﬁciency
would cause more generalized phenotypes affecting multiple tissues.
A possible reason for the speciﬁcity ofMagohMos2/þ phenotypes is the
expression of a redundant protein. Consistent with this, a homologous
Magoh2 gene is annotated in the genome (MGI.org), although its
expression and function in melanocytes is unknown. Another expla-
nation for the speciﬁcity of phenotypes is that melanoblasts and
neurons are especially sensitive to dosage of Magoh. Consistent with
this reasoning, when levels of Magoh and associated EJC components
are extensively depleted via morpholinos in Xenopus laevis, more
dramatic phenotypes are evident, including full-body paralysis and
aberrant neuronal and cardiac development (Haremaki et al., 2010).
In this study the authors also observed pigment cell loss with Magoh
morpholinos, however they did not elucidate the cellular mechanism
of this phenotype, nor how pigment cells are lost spatially and
temporally. Given our ﬁndings, we predict that proliferation defects
are at the root of many of the neural crest phenotypes observed in
Xenopus. Taken together, these studies indicate a conserved role for
the EJC in melanocyte and neural crest development.
Our results reveal that Magoh and EJC components are likely to
play roles in the etiology of melanocyte disorders arising during
development and in adulthood, including melanoma. Melanoma is
caused by over-proliferation of melanocytes. It is intriguing to note
that higher levels ofMagoh are observed in somemelanoma cell lines,
and that Magoh depletion from these cells arrests causes mitotic
arrest. This suggests the intriguing possibility that intervention of
Magoh expression or function could be used as a potential therapeutic
treatment of aggressive melanocyte cancers, including Melanoma.
Thus our study may open up new areas of research probing how
Magoh impacts melanoma progression and treatment.Conclusions
This study is the ﬁrst to dissect the in vivo requirement of
Magoh, or any core exon junction complex (EJC) component in
D.L. Silver et al. / Developmental Biology 375 (2013) 172–181 181neural crest development in mammals. Our study identiﬁes an
important regulator of melanocyte development. Moreover it
additionally helps elucidate general cellular mechanisms guiding
melanocyte development, and in particular the role of prolifera-
tion in expansion of melanocyte populations.Acknowledgments
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